ORTHOPEDIATRICS CORP 8-K

What Happened

• OrthoPediatrics Corp. filed a Form 8-K on February 26, 2026 (Item 7.01) to disclose that its executive officers have upcoming presentations to investors and analysts.
• Management intends to use the investor slide deck filed as Exhibit 99.1 (Investor Presentation dated February 2026), in whole or in part, during those presentations. The report was signed by Daniel J. Gerritzen, General Counsel and Secretary.

Key Details

• Filing date: February 26, 2026.
• Item reported: 7.01 — Regulation FD Disclosure (use of presentation material in investor/analyst meetings).
• Exhibit included: 99.1 — OrthoPediatrics Corp. Investor Presentation dated February 2026.
• The filing does not announce earnings, executive changes, mergers, or other material events beyond the disclosed presentations.

Why It Matters

• This 8-K makes management’s presentation materials available publicly under Regulation FD, so investors and analysts can review the same information management will present.
• Investors who follow OrthoPediatrics should review the attached February 2026 investor presentation for any updated metrics, strategy commentary, or disclosures management may be presenting; the 8-K itself does not provide financial results or other material announcements.